[
  {
    "ts": null,
    "headline": "Tracking Tweedy Browne Portfolio - Q3 2024 Update",
    "summary": "Tweedy Browne's 13F portfolio value drops to $2.10B with reductions in top positions like Berkshire Hathaway and Alphabet. Read an update on the portfolio here.",
    "url": "https://finnhub.io/api/news?id=95e30e21a5ecd4ff7a3e46256e2f327f543e5f56f2078576e636f34b699dc5ee",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731962146,
      "headline": "Tracking Tweedy Browne Portfolio - Q3 2024 Update",
      "id": 131461978,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/953164652/image_953164652.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Tweedy Browne's 13F portfolio value drops to $2.10B with reductions in top positions like Berkshire Hathaway and Alphabet. Read an update on the portfolio here.",
      "url": "https://finnhub.io/api/news?id=95e30e21a5ecd4ff7a3e46256e2f327f543e5f56f2078576e636f34b699dc5ee"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market",
    "summary": "Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=981b9fd697ba046e4980dd6b9ebc9d9bcbb04c4ba44f9100ca2a7fedfcbc1787",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731948060,
      "headline": "Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market",
      "id": 131475767,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=981b9fd697ba046e4980dd6b9ebc9d9bcbb04c4ba44f9100ca2a7fedfcbc1787"
    }
  },
  {
    "ts": null,
    "headline": "3 Growth Stocks You Can Buy Right Now Without Any Hesitation",
    "summary": "Here's why they view Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX) as growth stocks you can buy right now without any hesitation.  Prosper Junior Bakiny (Eli Lilly): For those looking for top growth stocks to buy right now, it's a great time to consider investing in one of the best-performing healthcare giants in recent years: Eli Lilly.  The pharmaceutical company is having its worst month in quite some time.",
    "url": "https://finnhub.io/api/news?id=cacddb833478bcca797c3519c8cae47f78677b822779a3417c9d429701155d80",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731927780,
      "headline": "3 Growth Stocks You Can Buy Right Now Without Any Hesitation",
      "id": 131440268,
      "image": "https://g.foolcdn.com/editorial/images/797880/happy-stock-investor-holding-smartphone.jpg",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Here's why they view Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX) as growth stocks you can buy right now without any hesitation.  Prosper Junior Bakiny (Eli Lilly): For those looking for top growth stocks to buy right now, it's a great time to consider investing in one of the best-performing healthcare giants in recent years: Eli Lilly.  The pharmaceutical company is having its worst month in quite some time.",
      "url": "https://finnhub.io/api/news?id=cacddb833478bcca797c3519c8cae47f78677b822779a3417c9d429701155d80"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy",
    "summary": "Zoetis, a leading animal health company, has shown impressive growth with a 17.55% CAGR since its IPO. Read why I rate ZTS stock a Buy now.",
    "url": "https://finnhub.io/api/news?id=b02e8a4d54768a2158d8e4696333123f7e491d50d8bf941ea6c0fab1b2b86d91",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731903372,
      "headline": "Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy",
      "id": 131438224,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/601800909/image_601800909.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Zoetis, a leading animal health company, has shown impressive growth with a 17.55% CAGR since its IPO. Read why I rate ZTS stock a Buy now.",
      "url": "https://finnhub.io/api/news?id=b02e8a4d54768a2158d8e4696333123f7e491d50d8bf941ea6c0fab1b2b86d91"
    }
  }
]